BUY Global Health Limited — Prabhudas Lilladher
byPrabhudas LilladherHorizon: NA (inferred 1 year)18 May 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·1 Aug · 2d ago
Medanta operator Global Health posts record operating performance in Q1 despite flat profit
NewsCnbc-Tv18·30 Jul · 3d ago
Global Health Ltd reported its Q1 FY27 results, showing highest ever quarterly Total Income of INR 13,262 million (up 26.2% YoY) and EBITDA of INR 3,153 million (up 23.5% YoY). The company also added
BSE · Company Update·30 Jul · 3d ago
2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·24 Jul · 1w ago
Global Health Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·30 Jul · 3d ago
Outcome of Board Meeting held today i.e. July 30, 2026, to consider Unaudited Financial Results for Quarter ended June 30, 2026.
BSE · Board Meeting·30 Jul · 3d ago
Global Health Ltd approves 20,000 ESOPs for one employee
NewsGoogle News·30 Jul · 3d ago
Global Health: Approves 20,000 ESOPs Grant to One Employee
NewsGoogle News·30 Jul · 4d ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Global Health
- BUY — Jefferies India1 Oct 2026 · ~1 year · target ₹1,660 · Active
- BUY — Emkay Global1 Oct 2026 · ~1 year · target ₹1,500 · Active
- BUY — Deven Mehata, IDBI Capital Markets and Securities25 Sept 2026 · ~2 weeks · target ₹1,625 · SL hit
- BUY — Shrikant Chouhan, Kotak Securities24 Sept 2026 · ~3 months · target ₹1,700 · Active
- BUY — IDBI Capital22 Sept 2026 · ~2 weeks · target ₹1,610 · SL hit
More from Prabhudas Lilladher
- BUY Sai Life Sciences21 Oct 2026 · ~1 year · target ₹1,620 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹200 · Active
- BUY Nestle India15 Oct 2026 · ~1 year · target ₹1,526 · Active
- BUY Tata Elxsi14 Oct 2026 · ~1 year · target ₹3,790 · Target hit
- SELL Avenue Supermarts12 Oct 2026 · ~3 months · target ₹3,214 · Target hit

